×

Get the Prostate Cancer Patient Guide as a digital download or free mailed copy.

Click here.

Breaking News: FDA Approves Talazoparib + Enzalutamide for Metastatic Castration-Resistant Prostate Cancer

Breaking News: FDA Approves Talazoparib + Enzalutamide for Metastatic Castration-Resistant Prostate Cancer

The FDA has approved a new medication, talazoparib, in combination with enzalutamide for patients with metastatic castration-resistant prostate cancer (mCRPC) who also have mutations in certain genes involved in DNA repair....Read More

PSMA PET Imaging

PSMA PET Imaging

PSMA PET is a newer, highly sensitive imaging scan that can detect prostate cancer metastases much earlier, when they are much smaller. It is approved for two types of patients:...Read More

Liquid Biopsy:  Catching Cancer Cells in the Blood

Liquid Biopsy: Catching Cancer Cells in the Blood

Snapshot of Cancer Metastatic prostate cancer looks a lot different from cancer that is confined to the prostate.  That’s because over time, as it develops the ability to spread beyond...Read More

More benefits of a plant-based diet: Better sexual and urinary function

More benefits of a plant-based diet: Better sexual and urinary function

After a prostate cancer diagnosis, patients often wonder what they can do to reduce the chance of their cancer worsening or recurring, to improve their recovery after treatment, or simply...Read More

Colorful Potluck Salad

Colorful Summer Potluck Salad

PCF’s Home Run Challenge wraps on Father’s Day, which brings us to our final installment of Game Day recipes! Whether you’re celebrating with a family BBQ or having friends over...Read More

Breaking News: FDA Approves Combination of Olaparib + Abiraterone for Metastatic Castration-Resistant Prostate Cancer in Patients with BRCA Gene Mutations

Breaking News: FDA Approves Combination of Olaparib + Abiraterone for Metastatic Castration-Resistant Prostate Cancer in Patients with BRCA Gene Mutations

The U.S. FDA has approved olaparib in combination with abiraterone (plus prednisone or prednisolone) for patients with metastatic castration-resistant prostate cancer (mCRPC) who also have a mutation in specific genes...Read More

Doc_discussino_part1_745x510

Prostate Cancer Survivorship, Part 1

            Survivor.  What does that word bring to mind?  (Besides, of course, the name of the rock band whose song, “Eye of the Tiger,” went double-platinum in 1982 and was...Read More

Hands_part2_745x510

Prostate Cancer Survivorship, Part 2

Matters of Survivorship: Sexual Health If you’re dealing with prostate cancer – the disease itself, or the aftermath of treatment – then you are dealing with issues of survivorship, says...Read More

Blocks_part3_745x510

Prostate Cancer Survivorship, Part 3

Matters of Survivorship:  Fighting Back on ADT ADT will try to affect your overall health, but here’s the good news:  you can fight back, says PCF-funded medical oncologist Alicia Morgans,...Read More

One-Year Update: A Beacon of Hope for Others

One-Year Update: A Beacon of Hope for Others

More than a year ago, Matt Fish kindly shared his remarkable story with PCF. A Veteran, Matt was diagnosed with prostate cancer at age 45. After a prostatectomy, his PSA...Read More